When City Manager Aaron Busch attended his first Biotech International conference as a member of the city’s staff, he found ...
VALENCIA, Spain, Nov. 11, 2024 /PRNewswire/ -- ARTHEx Biotech S.L., a clinical-stage ... today announced an oral presentation at the upcoming TIDES Europe Annual Meeting, being held November ...
Greetings, and welcome to the Moleculin Biotech Quarterly Update Conference Call and Webcast. At this time, all participants are in listen only mode. [Operator Instructions] A question-and-answer ...
BioSpace takes a look at the headlines across a heavy earnings week for biotechs, checking in on Allogene, Rapport and more.
Wa'el Hashad Wa'el Hashad, CEO, Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B™ in rare pediatric disease HLHS has ...
News Medical on MSN10d
Advancing vaccine development through green biotechnologyThe diseases hepatitis B (HBV) and C (HCV) remain a significant health threat worldwide, causing approximately 1.3 million deaths each year.
The oral presentation also included discussion of ... About CyanVac and Blue Lake Biotechnology CyanVac LLC and its affiliate, Blue Lake Biotechnology, Inc., are developing intranasal vaccines ...
SLN ("Silence" or "the Company"), a global clinical stage biotechnology company committed to transforming people's lives by silencing diseases ...
Viking Therapeutics highlights VK2735's promising weight loss data at ObesityWeek 2024, with up to 14.7% reduction and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback